Arşiv Kaynak Tarama Dergisi · Jun 17, 2026

The Effect of Sirtuin 1 (SIRT1) Signaling Networks on Cardiovascular Diseases

By Pehlivan E, Köseli İ, Ozsarlak‐Sozer G

Sirtuins are NAD⁺-dependent deacylases located within the metabolic hub of cells. This protein family, found in almost all species, is highly evolutionarily conserved. Proteomic studies show that sirtuins regulate metabolic networks to coordinate the cellular stress response. Dysregulation of sirtuins is associated with mitochondrial dysfunction and with diseases such as diabetes, cardiovascular diseases, neurodegeneration, and cancer. Seven sirtuin genes (sirtuins 1-7) have been identified in mammals. However, these proteins have varying mechanisms of action due to differences in their terminal structures. SIRT1, which we will discuss, plays an important role in regulating a wide variety of physiological processes by regulating multiple mechanisms through the deacetylation of multiple substrates. Deficiency of SIRT1, which also plays a critical role in controlling cellular aging processes, is associated with increased oxidative stress and the accumulation of reactive oxygen species (ROS). This causes cellular and organ damage and accelerates the aging process. Cardiovascular diseases encompass a broad spectrum of diseases affecting the heart and vascular system. SIRT1 is a protein complex that plays an important role in the development of cardiovascular diseases. Activation of sirtuins or nicotinamide adenine dinucleotide (NAD⁺) repletion induces angiogenesis, insulin sensitivity, and other health benefits in models of age-related cardiovascular and metabolic diseases. Because SIRT1 can deacetylate different substrates such as PPAR-γ, PGC-1α, FoxO, NF-κB, and p53, it has multifaceted cardiovascular biological functions, such as reducing inflammation, inhibiting cardiomyocyte apoptosis, defending against myocardial oxidative stress, counteracting myocardial remodeling, maintaining myocardial energy balance, supporting autophagic clearance, and preventing telomere shortening. This review examined the relationships of SIRT1 with eNOS, NF-κB, AMPK, FOXO, PGC1α, mTOR, and p53, which are signaling networks in cardiovascular protection. Human clinical trials that activate SIRT1 or increase NAD⁺ levels are ongoing and show promise for improving cardiovascular diseases.

doi.org/10.17827/aktd.1761387Open accessMechanisms

AgingResearch.News